389088-33-9

Basic information

• Product Name: Benzenemethanamine, N-(4-bromo-2,6-difluorophenyl)-N-(phenylmethyl)-
• CAS NO: 389088-33-9
• Molecular Formula: C20H16BrF2N
• Molecular Weight: 388.255
• Mol File: 389088-33-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzenemethanamine, N-(4-bromo-2,6-difluorophenyl)-N-(phenylmethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, N-(4-bromo-2,6-difluorophenyl)-N-(phenylmethyl)-(389088-33-9)
• EPA Substance Registry System: Benzenemethanamine, N-(4-bromo-2,6-difluorophenyl)-N-(phenylmethyl)-(389088-33-9)

Safety Data

• Hazardous Substances Data: 389088-33-9(Hazardous Substances Data)

Upstream product

• 5509-65-9 2,6-difluoroaniline 
• 100-39-0 benzyl bromide 
• 67567-26-4 4-bromo-2,6-difluoroaniline 

Downstream Products

• 1386949-50-3 tert-butyl 4-(4-amino-3,5-difluorophenyl)piperazine-1-carboxylate 
• 1386949-49-0 tert-butyl-4-(4-(dibenzylamino)-3,5-difluorophenyl)piperazine-1-carboxylate 
• 454217-41-5 dibenzyl-(2,4-difluoro-6,7,8,9-tetrahydro-5H-carbazol-3-yl)-amine 
• 454217-43-7 3-dibenzylamino-2,4-difluoro-9-(prop-2-yl)carbazole 
• 454217-40-4 [4-(N'-benzhydrylidene-hydrazino)-2,6-difluoro-phenyl]-dibenzyl-amine 

Relevant articles and documents

BICYCLIC INHIBITORS OF ALK

The present invention relates to compounds of formula (1) or pharmaceutical acceptable salts, wherein R1, X, Y, Z, A, B, G1, and n are defined in the description. The present invention relates also to compositions containing said compounds which are useful for inhibiting kinases such as ALK and methods of treating diseases such as cancer.

Liquid-crystalline medium

A liquid-crystalline medium based on a mixture of polar compounds of positive dielectric anisotropy, which comprises one or more compounds of the formula I where R1, A1, A2, Z1, Z2, L1, Ls